Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Int J STD AIDS ; 5(2): 108-12, 1994.
Article in English | MEDLINE | ID: mdl-8031911

ABSTRACT

A retrospective chart review was conducted for one year to determine cervical cytological abnormalities and their distribution among women attending a STD clinic, and to analyse cervical cytologies by STD diagnosis and history or presence of genital warts. Analysis was performed on 790 Pap smears. Most (60%) cytologies were benign. Prevalence of STD among CIN-1 cytologies (78%) was significantly higher (P = 0.02) than among benign cytologies (46%). Commonest cytologies presenting among youngest age groups were CIN-1/condyloma, CIN-1, CIN-2. Women with preceding or concurrent clinical HPV infection had significantly more HPV associated changes on cytology (P < 0.001) than women with no such history. The presentation of cytological abnormalities considered to be precursors to cervical cancer among sexually active young women demonstrates the importance of Pap smear testing of STD clinic populations.


Subject(s)
Condylomata Acuminata/epidemiology , Condylomata Acuminata/pathology , Mass Screening , Papanicolaou Test , Population Surveillance , Sexually Transmitted Diseases/epidemiology , Sexually Transmitted Diseases/pathology , Uterine Cervical Diseases/epidemiology , Uterine Cervical Diseases/pathology , Uterine Cervical Dysplasia/epidemiology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/pathology , Vaginal Smears , Adult , Age Distribution , Condylomata Acuminata/complications , Condylomata Acuminata/prevention & control , Female , Humans , Prevalence , Retrospective Studies , Risk Factors , Sexually Transmitted Diseases/complications , Sexually Transmitted Diseases/prevention & control , Uterine Cervical Diseases/complications , Uterine Cervical Diseases/prevention & control , Uterine Cervical Neoplasms/complications , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Dysplasia/complications , Uterine Cervical Dysplasia/prevention & control
2.
Ann Intern Med ; 119(1): 16-22, 1993 Jul 01.
Article in English | MEDLINE | ID: mdl-8498758

ABSTRACT

OBJECTIVE: To compare the efficacy and tolerability of minocycline versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. DESIGN: Randomized, double-blind trial. SETTING: Sexually transmitted disease clinics. PATIENTS: 151 men and 102 women with nongonococcal urethritis, mucopurulent cervicitis or whose sexual partner had either condition or a positive culture for Chlamydia trachomatis. INTERVENTIONS: Minocycline, 100 mg nightly, or doxycycline, 100 mg twice daily, each administered for 7 days. MEASUREMENTS: At each visit (days 14 +/- 3, 28 +/- 5, and 49 +/- 7) patients were questioned regarding symptoms, signs, drug compliance, and sexual contact. Cultures for C. trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis were obtained at each visit. RESULTS: 253 patients were enrolled (133, doxycycline; 120, minocycline). Chlamydia trachomatis was initially isolated from 31% of men and 39% of women. Men with a positive smear had a higher symptom/sign score (P < 0.001) and were more likely to have chlamydia (P = 0.004). Positive endocervical smears were not associated with symptoms or signs (P > 0.2) but correlated with isolation of chlamydia (P < 0.001). One hundred sixty-two patients (64%) completed the study. The proportion with urethritis or cervicitis did not differ by treatment group at any follow-up visit (P > 0.08). Unprotected sexual contact did not affect clinical or microbiological cure rates. Adverse effects occurred more frequently in the doxycycline group (men: 43% versus 26%; P = 0.05; women: 62% versus 35%; P = 0.009). Although the proportion with dizziness did not differ by drug administered (P = 0.1), dizziness was reported more often by women (11% versus 3%). CONCLUSIONS: Minocycline, 100 mg nightly, was as effective as doxycycline, 100 mg twice daily, each given for 7 days in the treatment of nongonococcal urethritis and mucopurulent cervicitis. Vomiting and gastrointestinal upset occurred more frequently in the doxycycline group.


Subject(s)
Doxycycline/therapeutic use , Minocycline/therapeutic use , Urethritis/drug therapy , Uterine Cervicitis/drug therapy , Adolescent , Adult , Chlamydia Infections/drug therapy , Chlamydia trachomatis , Double-Blind Method , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Male , Mycoplasma Infections/drug therapy , Recurrence , Suppuration , Ureaplasma Infections/drug therapy , Ureaplasma urealyticum , Urethritis/microbiology , Uterine Cervicitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...